Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

GALT holding history

Galectin Therapeutics Inc in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GALT overviewAll 13F holders of GALTFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of GALT by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−10,000−100.0%Sold outHolders
Q3 202510,000$42.4K<0.1%00.0%UnchangedHolders
Q2 202510,000$21.1K<0.1%00.0%UnchangedHolders
Q1 202510,000$12.2K<0.1%−9,000−47.4%ReducedHolders
Q4 202419,000$24.5K<0.1%−11,771−38.3%ReducedHolders
Q3 202430,771$84.6K<0.1%−18,000−36.9%ReducedHolders
Q2 202448,771$110.2K<0.1%+1,116+2.3%AddedHolders
Q1 202447,655$113.9K<0.1%+5,000+11.7%AddedHolders
Q4 202342,655$70.8K<0.1%+4,830+12.8%AddedHolders
Q3 202337,825$72.6K<0.1%+5,000+15.2%AddedHolders
Q2 202332,825$47.3K<0.1%00.0%UnchangedHolders
Q1 202332,825$68.9K<0.1%+150.0%AddedHolders
Q4 202232,810$37.1K<0.1%00.0%UnchangedHolders
Q3 202232,810$53.0K<0.1%−12,525−27.6%ReducedHolders
Q2 202245,335$59.0K<0.1%−9,975−18.0%ReducedHolders
Q1 202255,310$89.0K<0.1%00.0%UnchangedHolders
Q4 202155,310$114.0K<0.1%−2,000−3.5%ReducedHolders
Q3 202157,310$222.0K<0.1%−4,000−6.5%ReducedHolders
Q2 202161,310$196.0K<0.1%−4,000−6.1%ReducedHolders
Q1 202165,310$142.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.